van Rhee, K. P. http://orcid.org/0000-0001-9195-9783
Knibbe, C. A. J. http://orcid.org/0000-0001-9893-4415
van der Linden, P. D. http://orcid.org/0000-0002-3551-7005
Brüggemann, R. J. M. http://orcid.org/0000-0002-7618-725X
Article History
Accepted: 3 December 2023
First Online: 5 January 2024
Declarations
:
: Not applicable.
: RB declares no interest with regard to this work. Outside of this work, he has served as consultant to and has received unrestricted research grants from Astellas Pharma Inc., F2G, Gilead sciences, Merck Sharpe and Dohme Corp., Mundipharma Inc., and Pfizer Inc. All payments were invoiced by the Radboud University Medical Center. PvdL declares membership of the compliance committee of STIZON and is treasurer of the Dutch Working party on Antibiotic Policy (SWAB). The remaining authors have no conflict of interest to declare.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: KR, CK, PvdL, RB helped with conceptualisation of this personal view. KR helped with the original draft and visualisation. KR, CK and RB conducted data curation and formal analysis. CK, PvdL, RB helped with review and editing of the draft.
: Not applicable.
: Not applicable.